Salt-inducible Kinases May Be Promising Therapeutic Targets for Crohn’s, Other Autoimmune Diseases

Salt-inducible Kinases May Be Promising Therapeutic Targets for Crohn’s, Other Autoimmune Diseases
Salt-inducible kinases (SIK) may be a novel therapeutic target for inflammation in autoimmune diseases such as Crohn’s disease, psoriasis, and arthritis, according to a report published in the Journal of Leukocyte Biology, titled “SIK inhibition in human myeloid cells modulates TLR and IL-1R signaling and induces anti-inflammatory phenotype.“ Macrophages are cells from the innate immune

Knowledge is power when living with IBD.

Get access to the web’s leading IBD news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *